Unable to display preview. Download preview PDF. Skip to main content. This service is more advanced with JavaScript available. Advertisement Hide.

Author:Voodoogore Arashimuro
Language:English (Spanish)
Published (Last):8 April 2016
PDF File Size:16.93 Mb
ePub File Size:8.5 Mb
Price:Free* [*Free Regsitration Required]

Background: Although peripheral nervous system involvement is common in eosinophilic granulomatosis with polyangiitis EGPA , central nervous system CNS manifestations are poorly described. We also undertook a systematic literature review. Results: We analyzed 26 personal cases and 62 previously reported cases. After a mean follow-up of 36months, 11 patients died including 5 from intracerebral hemorrhages.

Conclusion: EGPA-related CNS manifestations form 4 distinct neurological pictures: ischemic lesions, intracerebral hemorrhages, cranial nerve palsies and loss of visual acuity.

Such manifestation should prompt practitioners to consider EGPA in such conditions. Long-term neurological sequelae were common, and intracerebral hemorrhages had the worst prognostic impact. Keywords: Cerebral hemorrhage; Cranial nerve palsy; Eosinophilic granulomatosis with polyangiitis; Optic neuritis; Stroke. This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable.

Search: Search. Advanced Clipboard. Create file Cancel. Email citation To:. Format: Summary Summary text Abstract Abstract text. Send email Cancel. Add to Collections Create a new collection Add to an existing collection. Name your collection: Name must be less than characters.

Choose a collection: Unable to load your collection due to an error Please try again. Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again. Your saved search Name of saved search:. Search terms:. Test search terms. Would you like email updates of new search results? Email: change. Frequency: Monthly Weekly Daily. Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items.

Send even when there aren't any new results. Optional text in email:. Save Cancel. Create a file for external citation management software Create file Cancel. Full-text links Cite Favorites.

Abstract Background: Although peripheral nervous system involvement is common in eosinophilic granulomatosis with polyangiitis EGPA , central nervous system CNS manifestations are poorly described.

Similar articles A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis. Quan MV, et al. BMC Pulm Med. Gilyarov MY, et al. PMID: Russian. Oiwa H, et al. Intern Med. Epub Sep Successful use of Rituximab in a patient with recalcitrant multisystemic eosinophilic granulomatosis with polyangiitis. Najem CE, et al. BMJ Case Rep. Choi CB, et al. Yonsei Med J. Show more similar articles See all similar articles.

Cited by 7 articles Magnetic resonance imaging of intraocular optic nerve disorders: review article. Kanda T, et al. Pol J Radiol. Markousis-Mavrogenis G, et al. J Clin Med. Factors driving olfactory loss in patients with chronic rhinosinusitis: a case control study. Schlosser RJ, et al. Int Forum Allergy Rhinol.

PMID: A delayed diagnosis of eosinophilic granulomatosis with polyangiitis complicated with extensive artery occlusion of lower extremities in children: case report and literature review. Liu X, et al. Pediatr Rheumatol Online J. Xu D, et al. Front Neurol. Show more "Cited by" articles See all "Cited by" articles. Publication types Multicenter Study Actions. Review Actions. Systematic Review Actions. MeSH terms Adult Actions. Aged Actions. Female Actions.

Humans Actions. Male Actions. Middle Aged Actions. Prognosis Actions. Retrospective Studies Actions. Treatment Outcome Actions. Full-text links [x] Elsevier Science.

Copy Download.


Vasculites cutanées et cutanéo-systémiques

Rituximab has been proven superior over conventional immunosuppressant therapy for remission maintenance. Its efficacy on the vasculitis is less clear. This article reviews the current role for targeted immunotherapy in AAV, its validated indications, and avenues for further development. Rituximab in these indications is not less effective than cyclophosphamide and is particularly useful in patients with refractory or relapsing disease, women of childbearing potential, and patients previously treated with cyclophosphamide. Rituximab is more effective than cyclophosphamide for treating relapses. For remission maintenance therapy, which is indispensable, rituximab has been proven superior over conventional immunosuppressive treatment.


Pituitary dysfunction is a rare manifestation of granulomatosis with polyangiitis GPA Wegener. The main aim of this multicenter retrospective study was to describe the characteristics and outcomes of pituitary manifestations in patients with GPA included in the French Vasculitis Study Group database. Among the GPA patients included in the database, 9 1. The median age at diagnosis of GPA and pituitary involvement was 46 and Pituitary involvement was present at onset of GPA in 1 case and occurred later in 8 patients after a median follow up of Magnetic resonance imaging was abnormal in 7 patients. The most common lesions were an enlargement of the pituitary gland, thickening of the pituitary stalk, and loss of posterior hypersignal on T1-weighed images.



Related Articles